Research Article

Intravitreal ranibizumab in the management of acute central serous Chorioretinopathy

Purpose: To evaluate the efficacy of ranibizumab in hastening the recovery of acute CSCR when given immediately at time of diagnosis.

Read Full Article HTML DOI: 10.29328/journal.hceo.1001007 Citation Views: 3606